Long‐term follow‐up of a young male who developed acute macular neuroretinopathy following COVID‐19 vaccination

Shunsuke Ikema,Gen Miura,Daisuke Shimizu,Takayuki Baba
DOI: https://doi.org/10.1002/ccr3.8181
2023-11-01
Clinical Case Reports
Abstract:Key Clinical Message This report presents the clinical findings and prognosis of a healthy male patient who developed acute macular neuroretinopathy after COVID‐19 vaccination. Abnormal findings improved about 1 month after the onset and disappeared 3 months later. The subjective symptoms disappeared in 3 months, and no recurrence was observed for 1 year.
What problem does this paper attempt to address?